Blood Pressure LoweringTreatment Trialists Collaboration.Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs; results of prospectively designed overviews of randomised trials. Lancet2000; 355:1955-64.
2.
MacMahon S., Rodgers A. The Effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol1993; 4:265-71.
3.
MacMahon S., Peto R., Cutler J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet1990; 335: 765-74.
4.
Medical Research CouncilWorking Party.MRC trial of treatment of mild hypertension: principal results. BMJ1985; 291:97-104.
5.
Veterans Administrative Cooperative Study Group on Antihypertensive Agents.Effects of treatment on morbidity in hypertension; results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA1967; 202: 116-22.
6.
Veterans Administrative Cooperative Study Group on Antihypertensive Agents.Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 90 through 114 mmHg.JAMA1970; 213: 1143-52.
7.
Staessen J.,Fagard R.,Thijs L. et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet1997; 350: 757-64.
8.
Sever P.ACE inhibitors in hypertension: still a shortage of evidence. JRAAS2000; 1: 117-8.
9.
HOPE (Heart Outcomes Prevention Evaluation) study investigators.effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med2000; 342: 145-53.
10.
Williams B.The renin-angiotensin-system and cardiovascular disease: hope or hype?JRAAS2000; 1: 142-6.
11.
Brown M., Palmer C., Castaigne A. et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-Acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a goal in hypertension treatment (INSIGHT) . Lancet2000; 356: 366-72.
12.
Hansson L., Lindholm L., EkbomT. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity.The Swedish Trial in Old Patients With Hypertension-2 Study. Lancet1999; 354: 1751-6.
13.
Hannson L., Hedner T., Lund-Johansen P. et al. Randomised trial of effects of calcium antagonists compared with diuretics snd β-Blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study. Lancet2000; 356: 359-65.
14.
Hannson K., Lindholm L., Niskanen L. et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) Randomised Trial. Lancet1999; 353: 611-6.
15.
Davis BR, Cutler JA, Gordon DJ et al. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). Am J Hypertens1996;9:34260.
16.
Dahlof B., Sever PS, Poulter NR, Wedel H.On behalf of the ASCOT Steering Committee. International Society of Hypertension 1998. J Hypertens1998; 16 (Suppl 2): S212.
17.
World Health Organisation-International Society of Hypertension Blood Pressure Lowering Treatment Trialist's Collaboration. Protocol For prospective collaborative overviews of major randomised trials of blood-pressure lowering treatments. J Hypertens1998; 16: 127-37.
18.
Estacio R., Jeffers B., Hiatt W., Biggerstaff S., Gifford N., Schrier R.The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependant diabetes and hypertension. N Engl J Med1998; 338:645-52.
19.
Rafflenbeul W.Prognostic Benefits of anti hypertensive therapy: concern about another `solid` matter-analysis. Br J Cardiol2000; 7: 703-8.
20.
Pahor M., Psaty BM, Alderman MH et al. Health outcomes associated with calcium antagonists compared with other first-line anti hypertensive therapies.A meta analysis of randomised controlled trials. Lancet2000; 356: 1949-54.
21.
He J., Whelton PKSelection of initial anti hypertensive drug therapy. Lancet2000; 356:1942-3.
